Ownership history in Nepsis Inc. · 6 quarters on record
This page tracks every 13F SEC filing in which Nepsis Inc. reported a position in UNITED THERAPEUTICS CORP DEL (UTHR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 43,760 | -656 | -1.5% | 6.59% | $21.3M | $487.25 |
| 2025 Q3 | REDUCED | 44,416 | -3,356 | -7.0% | 5.90% | $18.6M | $419.21 |
| 2025 Q2 | REDUCED | 47,772 | -10,802 | -18.4% | 3.82% | $13.7M | $287.35 |
| 2025 Q1 | ADDED | 58,574 | +3,653 | +6.7% | 4.46% | $18.1M | $308.27 |
| 2024 Q4 | ADDED | 54,921 | +3,113 | +6.0% | 4.84% | $19.4M | $352.84 |
| 2024 Q3 | INITIATED | 51,808 | — | — | 4.40% | $18.6M | $358.35 |
As of 2025 Q4 — sorted by position size